MaxCyte, Inc. provided a preliminary update on financial results for the fourth quarter and full year 2025, revealing key insights into its performance and financial position.
The company expects core revenue for the full year to range between $29.5 million and $29.6 million, indicating stability in its primary revenue stream.
As of December 31, 2025, MaxCyte anticipates its total cash, cash equivalents, and investments to be approximately $155.6 million, highlighting a strong liquidity position.
Core Revenue
MaxCyte anticipates core revenue to fall within the $6.6 million to $6.7 million range for the fourth quarter of 2025, with a full-year forecast of $29.5 million to $29.6 million, demonstrating consistent performance in its primary revenue segment.
SPL Program Revenue
The company projects SPL Program revenue to be between $0.4 million and $0.6 million for the fourth quarter and $3.3 million to $3.5 million for the full year, showcasing a supplementary revenue stream in its financial results.
Financial Progress
Despite facing challenges in 2025, MaxCyte is strategically aiming for profitability by optimizing its resource allocation and enhancing cost efficiencies, positioning itself for sustainable growth and financial success.
- MaxCyte's ability to meet its core revenue guidance amidst macroeconomic challenges underscores the resilience and stability of its revenue streams, instilling confidence in its operational capabilities and market positioning.
- The company's significant efforts in resource alignment and cost optimization signal a proactive approach towards building a leaner and more efficient operational structure for future growth and profitability, setting a strong foundation for sustainable financial performance.
MaxCyte's preliminary financial results for 2025 not only highlight its resilience in navigating the industry challenges but also signify a strategic transformation towards operational efficiency and sustainable growth in the cell-engineering sector, positioning the company for enhanced market competitiveness and value creation.